Nuwellis (NUWE) EBITDA Margin Growth (5y) (2018 - 2026)
Powered by 
Analysis
Nuwellis (NUWE) EBITDA Margin Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,749.00 |
| Mar 31, 2026 | 8,196.00 |
| Dec 31, 2025 | 10,885.00 |
| Sep 30, 2025 | 10,193.00 |
| Jun 30, 2025 | 4,195.00 |
| Mar 31, 2025 | 11,947.00 |
| Dec 31, 2024 | 22,244.00 |
| Sep 30, 2024 | 29,526.00 |
| Jun 30, 2024 | 15,830.00 |
| Mar 31, 2024 | 13,315.00 |
| Dec 31, 2023 | 14,288.00 |
| Sep 30, 2023 | 18,063.00 |
| Jun 30, 2023 | 13,823.00 |
| Mar 31, 2023 | 9,944.00 |
| Dec 31, 2022 | 66,560.00 |
| Sep 30, 2022 | 10,933.00 |
| Jun 30, 2022 | 9,488.00 |
| Mar 31, 2022 | 2,688.00 |
| Dec 31, 2021 | 14,683.00 |
| Sep 30, 2021 | 46,469.00 |